Cobalamin C Deficiency: Case Report of Two Different Clinical Presentations
Journal Title: Journal of Neurology and Experimental Neuroscience - Year 2016, Vol 2, Issue 2
Abstract
Cobalamin C deficiency (CblC) is the most frequent inborn error of cobalamin (Cbl) metabolism, which has a wide clinical spectrum. Cbl C defect causes the accumulation of methylmalonic acid and homocysteine and decreased methionine synthesis. Here we presented two distinct clinical forms of patients with CblC. First patient with early onset form was presented with failure to thrive, mild hypotonia, megaloblastic anemia and leukopenia at 2.5 months old. Second patient was presented with mental status changes, loss of speech, inability to walk and megaloblastic anemia at 12 years old. Laboratory analysis showed hyperhomocysteinemia, low plasma methionine levels and high urinary methylmalonic acid in both patients. Molecular analysis supported the diagnosis of CblC and treatment resulted in improvement of biochemical abnormalities, and neurologic findings in both patients.
Authors and Affiliations
Mehmet Gunduz, Ozlem Unal, Birce Dilge Taskin, Zeynep Selen Karalok
Urokinase-type Plasminogen Activator Induces Neurorepair in the Ischemic Brain
Urokinase-type plasminogen activator (uPA) is a serine proteinase that upon binding to its receptor (uPAR) catalyzes the conversion of plasminogen into plasmin on the cell surface. Recent studies indicate that neurons bu...
Posterior Reversible Encephalopathy Syndrome (PRES) Associated with Papilledema Mimicking Multiple Sclerosis and Boomerang Sign on Imaging: Report of Two Cases
Posterior reversible encephalopathy is a clinical syndrome of acute neurological symptoms like seizures, disturbed vision, headache, and altered mental state in the setting of renal failure, heart failure, blood pressure...
Acute Cocaine Exposure and Cerebrovascular Diseases: A Retrospective Clinical Study and Literature Review
Objective: To evaluate cocaine as a risk factor for Cerebrovascular Diseases (CVD). Introduction: Illicit substance consumption is an independent risk factor for CVD, however studies on such substances, particularly coca...
Report on the First Neurological Disorders Summit (NDS-2015)
Neurological Disorders Summit (NDS-2015) concluded successfully on July 08, 2015. The three day summit was organized by United Scientific Group during July 06-08, 2015 at DoubleTree By Hilton, San Francisco, USA. The eve...
Proceedings of the Third Neurological Disorders Summit (NDS-2017)
Discovery of genetic influence on craving by Blum, and Noble allowed more research on genetic determinants of mental and physical health. It led to DNA Customization of nutraceutical products in humans. One such product...